Rechavi, Y.; Shashar, M.; Lellouche, J.; Yana, M.; Yakubovich, D.; Sharon, N.
Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response. Vaccines 2021, 9, 977.
https://doi.org/10.3390/vaccines9090977
AMA Style
Rechavi Y, Shashar M, Lellouche J, Yana M, Yakubovich D, Sharon N.
Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response. Vaccines. 2021; 9(9):977.
https://doi.org/10.3390/vaccines9090977
Chicago/Turabian Style
Rechavi, Yoav, Moshe Shashar, Jonathan Lellouche, Moshe Yana, Daniel Yakubovich, and Nechama Sharon.
2021. "Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response" Vaccines 9, no. 9: 977.
https://doi.org/10.3390/vaccines9090977
APA Style
Rechavi, Y., Shashar, M., Lellouche, J., Yana, M., Yakubovich, D., & Sharon, N.
(2021). Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response. Vaccines, 9(9), 977.
https://doi.org/10.3390/vaccines9090977